Clinical Trials Directory

Trials / Terminated

TerminatedNCT00881023

Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration

A Multicenter, Randomized, Pivotal Study to Evaluate the Safety and Efficacy of the Cartilage Autograft Implantation System (CAIS) for the Surgical Treatment of Articular Cartilage Lesions of the Knee

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
DePuy Mitek · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The Cartilage Autograft Implantation System (CAIS) is designed as a single surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region. CAIS is indicated for the repair of articular cartilage lesions and osteochondritis dissecans (OCD) of the knee through cartilage regeneration.

Detailed description

The Cartilage Autograft Implantation System (CAIS) is a kit of devices that utilizes morselized autologous hyaline cartilage harvested arthroscopically, affixed onto a synthetic, resorbable implant using a fibrin sealant and implanted in a single surgical procedure. The system is designed as a surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region.

Conditions

Interventions

TypeNameDescription
PROCEDUREMicrofractureThe microfracture procedure is a standard method for treatment of cartilage damage in which the surgeon will clean the site of your cartilage damage and then will make several small holes in your bone to stimulate your bone marrow with the intention to repair the damaged area with new cartilage tissue
DEVICECartilage Autograft Implantation SystemA surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region

Timeline

Start date
2010-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2009-04-14
Last updated
2016-08-03

Locations

29 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT00881023. Inclusion in this directory is not an endorsement.